Prediabetes represents an early stage of glucose metabolism disorder with significant public health implications. Although traditional lifestyle interventions have demonstrated some efficacy in preventing the progression to type 2 diabetes, their limitations—such as lack of personalization, restricted real-time monitoring, and delayed intervention—are increasingly apparent. This article systematically explores the potential applications of continuous glucose monitoring (CGM) technology combined with artificial intelligence (AI) in the management of prediabetes. CGM provides real-time and dynamic glucose monitoring, addressing the shortcomings of conventional methods, while AI enhances the clinical utility of CGM data through deep learning and advanced data analysis. This review examines the advantages of integrating CGM and AI from three perspectives: precise diagnosis, personalized intervention, and decision support. Additionally, it highlights the unique roles of this integration in remote monitoring, shared decision-making, and patient empowerment. The article further discusses challenges related to data management, algorithm optimization, ethical considerations, and future directions for this technological integration. It proposes fostering multidisciplinary collaboration to promote the application of these innovations in diabetes management, aiming to deliver a more precise and efficient health management model for individuals with prediabetes.
Prediabetes, as an intermediary stage between normal glucose homeostasis and overt diabetes, affects an estimated 720 million individuals worldwide, highlighting the urgent need for proactive intervention strategies. Continuous glucose monitoring (CGM) emerges as a transformative tool, offering unprecedented insights into glycemic dynamics and facilitating tailored therapeutic interventions. This perspective scores the clinical significance of even slightly elevated fasting blood glucose levels and the critical role of early intervention. CGM technology provides real-time, continuous data on glucose concentrations, surpassing the constraints of conventional monitoring methods. Both retrospectively analyzed and real-time CGM systems offer valuable tools for glycemic management, each with unique strengths. The integration of CGM into routine care can detect early indicators of type 2 diabetes, inform the development of personalized intervention strategies, and foster patient engagement and empowerment. Despite challenges such as cost and the need for effective utilization through training and education, CGM’s potential to revolutionize prediabetes management is evident. Future research should focus on refining CGM algorithms, exploring personalized intervention strategies, and leveraging wearable technology and artificial intelligence advancements to optimize glycemic control and patient well-being.
Musculoskeletal pain imposes a significant burden due to its high prevalence and complex pathophysiology. This perspective paper examines the current knowledge regarding the underlying mechanisms of musculoskeletal pain conditions and explores the therapeutic potential of acupotomy. Preliminary evidence suggests that acupotomy holds promise in effectively alleviating pain, improving functional outcomes, and facilitating myofascial tissue healing in individuals with musculoskeletal pain. However, further studies are warranted to elucidate the precise mechanisms through which acupotomy modulates fascia and trigger points, thus influencing pain processing. The targeted and precise nature of acupotomy in addressing specific trigger points and promoting tissue healing offers a promising approach for managing musculoskeletal pain. Nevertheless, additional research is imperative to comprehensively understand its mechanisms of action and optimize treatment protocols. This perspective paper critically contributes valuable insights into the contemporary understanding of musculoskeletal pain and underscores the potential of acupotomy as a valuable treatment modality.